Our Science – Boyer Website
Paul L. Boyer, Ph.D.
Selected Publications |
1)
Gao L, Hanson MN, Balakrishnan M, Boyer PL, Roques BP, Hughes SH, Kim B, Bambara RA. Apparent defects in processive DNA synthesis, strand transfer, and primer elongation of Met-184 mutants of HIV-1 reverse transcriptase derive solely from a dNTP utilization defect. J. Biol. Chem. 283: 9196-205, 2008. [Journal] |
2)
Comin MJ, Vu BC, Boyer PL, Liao C, Hughes SH, Marquez VE. D-(+)-iso-methanocarbathymidine: a high-affinity substrate for herpes simplex virus 1 thymidine kinase. ChemMedChem. 3: 1129-34, 2008. [Journal] |
3)
Das K, Sarafianos SG, Clark AD, Boyer PL, Hughes SH, Arnold E. Crystal structures of clinically relevant Lys103Asn/Tyr181Cys double mutant HIV-1 reverse transcriptase in complexes with ATP and non-nucleoside inhibitor HBY 097. J. Mol. Biol. 365: 77-89, 2007. [Journal] |
4)
Boyer PL, Stenbak CR, Hoberman D, Linial ML, Hughes SH. In vitro fidelity of the prototype primate foamy virus (PFV) RT compared to HIV-1 RT. Virology. 367: 253-64, 2007. [Journal] |
5)
Boyer PL, Julias JG, Ambrose Z, Siddiqui MA, Marquez VE, Hughes SH. The nucleoside analogs 4'C-methyl thymidine and 4'C-ethyl thymidine block DNA synthesis by wild-type HIV-1 RT and excision proficient NRTI resistant RT variants. J. Mol. Biol. 371: 873-82, 2007. [Journal] |
6)
Boyer P, Clark P, Hughes S, Linial M, Rinke C, inventor; DHHS, assignee. Foamy Virus Mutant Reverse Transcriptase. Patent Pending, Filed in 2001. Application No. 0/478,442. Pending [Patent] |
This page was last updated on 7/25/2008.